Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany

Infection

Volumn 43, Issue 4, 2015, Pages 423-429

  Gross, Barbara N ^a   Steib Bauert, Michaela ^a   Kern, Winfried V ^a   Knoth, Holger ^b   Borde, Johannes P ^a   Krebs, Sabine ^c   Hug, Martin J ^a   Rothe, Ulrich ^d   Maier, Ludwig ^e   de With, Katja ^a,f  

^a UNIVERSITY OF FREIBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Antibiotic stewardship; Antifungal drugs; Antifungal stewardship; Hematology; Pharmacoepidemiology

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ARTICLE; CALCULATION; DRUG USE; GERMANY; HOSPITAL PHARMACY; HUMAN; INTENSIVE CARE UNIT; MEDICAL SERVICE; MULTICENTER STUDY (TOPIC); UNIVERSITY HOSPITAL; ANTIFUNGAL RESISTANCE; CANCER CENTER; CLINICAL TRIAL; DRUG UTILIZATION REVIEW; HEMATOLOGY; HOSPITAL DEPARTMENT; MULTICENTER STUDY; MYCOSES;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; DRUG UTILIZATION REVIEW; GERMANY; HEMATOLOGY; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MYCOSES; ONCOLOGY SERVICE, HOSPITAL; SURGERY DEPARTMENT, HOSPITAL;

EID: 84938419450     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-015-0742-5     Document Type: Article

References (22)

1. de With K, Steib-Bauert M, Knoth H, Dörje F, Strehl E, Rothe U, et al. Hospital use of systemic antifungal drugs. BMC Clin Pharmacol. 2005;5:1.
2. Mondain V, Lieutier F, Hasseine L, Gari-Toussaint M, Poiree M, Lions C, et al. A 6-year antifungal stewardship programme in a teaching hospital. Infection. 2013;41:621–8.
3. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, et al. Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Clin Microbiol Infect. 2012;18:E389–95.
4. Fournier P, Schwebel C, Maubon D, Vesin A, Lebeau B, Foroni L, et al. Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. J Antimicrob Chemother. 2011;66:2880–6.
5. Kim SH, Shin JH, Kim E-C, Lee K, Kim M-N, Lee WG, et al. The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study. Med Mycol. 2009;47:296–304.
6. Lai C-C, Chu C-C, Wang C-Y, Tsai H-Y, Cheng A, Lee Y-C, et al. Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan. Int J Antimicrob Agents. 2012;40:349–53.
7. Olaechea-Astigarraga PM, Alvarez-Lerma F, Palomar-Martínez M, Insausti-Ordeñana J, López-Pueyo MJ, Seijas-Betolaza I, et al. Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006–2010. Enferm Infect Microbiol Clin. 2012;30:435–40.
8. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50:291–322.
9. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.
10. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.
11. Ullmann AJ, Cornely OA, Donnelly JP, Akova M, Arendrup MC, Arikan-Akdagli S, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect. 2012;18:1–8.
12. Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012;18:9–18.
13. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18:19–37.
14. Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012;18:38–52.
15. Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect. 2012;18:68–77.
16. Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20:76–98.
17. Ananda-Rajah MR, Slavin MA, Thursky KT. The case for antifungal stewardship. Curr Opin Infect Dis. 2012;25:107–15.
18. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, et al. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010;10:150.
19. Nivoix Y, Launoy A, Lutun P, Moulin J-C, Phai Pang K-A, Fornecker L-M, et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother. 2012;67:2506–13.
20. Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol. 2012;33:338–45.
21. López-Medrano F, San Juan R, Lizasoain M, Catalán M, Ferrari JM, Chaves F, et al. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital. Clin Microbiol Infect. 2013;19:56–61.
22. Swoboda S, Lichtenstern C, Ober MC, Taylor LA, Störzinger D, Michel A, et al. Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs. Chemotherapy. 2009;55:418–24.